Sun Jin and Morgan’s paper published in Nature Communications
Vaccinated and finally all back together!
Keith’s manuscript on Fab-CHP conjugates to treat Rheumatoid Arthritis published in Bioconjugate Chemistry
Conjugation of collagen-hybridizing peptides (CHPs) to antibody fragments can improve treatment localization to sites of denatured collagen, potentially limiting on-target effects. Check it out!
Keith is awarded the University Graduate Research Fellowship
Congratulations to Keith Arlotta for receiving funding through the University of Utah Graduate School!
Publication! WIREs Nanomedicine and Nanobiotechnology – Antibody and antibody derivatives as cancer therapeutics
In-depth review of the current state of therapeutic anti-cancer antibodies and antibody derivatives. This review acts as a guide, detailing the effects of specific modifications on antibody function, stability, and half-life.
https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wnan.1556
Sam receives support through UROP
Congrats to Sam Hatch for receiving funding through the University of Utah Undergraduate Research Opportunity Program.
First paper on Target-Engaged Complementation published in Scientific Reports
A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays. Scientific Reports (2017) 7:8186
Scholarship! Sun Jin received a Skaggs Research Fellowship
Congratulations to Sun Jin Kim (bottom right) as one of four graduate students to receive a Skaggs Research Fellowship.
Much thanks to the College of Pharmacy and the ALSAM Foundation.
Lab receives UTAG Grant
University of Utah researchers have won six of the 20 University Technology Acceleration Grants (UTAG), a program that provides crucial funds to accelerate university-developed technologies from the idea stage to the market. The group is the first round of UTAG winners, funded by the Utah Science Technology and Research (USTAR) initiative.
Among the U’s winners are biochemist Danny Chou, bioinformatician Alistair Ward and pharmaceutical chemist Shawn Owen.
TEC highlighted at World Biomaterials Conference 2016
Our platform, Target-Engaged Complementation (TEC) was highlighted at the recent WBC.
Only 1 out 300+ talks was highlighted each day!
